摘要 |
The present invention relates to an N1-2-thiophene-2-ylethyl-N2-substituted biguanide derivate expressed in Chemical Formula 1, a pharmaceutically allowable salt thereof, a preparation method thereof, and a pharmaceutical composition containing the same as active ingredients. The N1-2-thiophene-2-ylethyl-N2-substituted biguanide derivate of the present invention shows a superior hypoglycemic action and a superior hypolipidemic action even at a low dosage as compared with conventional drugs, and thus can be used for prevention and treatment of diabetes, non-insulin-dependent diabetes, obesity, the metabolic syndrome and arteriosclerosis, or cancer involving P53 gene deficiency. |
申请人 |
HANALL PHARMACEUTICAL COMPANY, LTD.;KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY;KIM, SUNG WUK;JUN, SUNG SOO;CHEON, HYAE GYEONG;KIM, KWANG ROK;RHEE, SANG DAL;JUNG, WON HOON;LEE, JONG CHEOL |
发明人 |
KIM, SUNG WUK;JUN, SUNG SOO;CHEON, HYAE GYEONG;KIM, KWANG ROK;RHEE, SANG DAL;JUNG, WON HOON;LEE, JONG CHEOL |